WHO protests common drug names in trademarks

The WHO feels that the practice is not only against international ethics, but also increases the risk of wrong medication. INNs are names that help to identify the chemical composition of a pharmaceutical substance without having to use long and unwieldy chemical names.

Orchid gets USFDA nod for non-antibiotic drug
B’lore cos to stamp their names at Olympics
Ranbaxy plans trials for new drug
Indo-Pak trade: Cutting the Gordian knot
Now, Ranbaxy AIDS drug under US lens

Leave a Reply